Genetic immunization against Ebola virus in a guinea pig model advances our understanding of the immune response in this disease (pages 37–42).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Patty, S.R., Ebola Virus Hemorrhagic Fever, (ed. Patty, S.R.) 1–436 (Elsevier, Amsterdam, 1978).
Clegg, J.C.S. & Sanchez, A. Vaccines against arenaviruses and filoviruses. In New Generation Vaccines (eds Levine, M.M., Woodrow, G.C., Kaper, J.B. & Cobon, G.S.) 749–765 (Marcel Dekker, Inc, New York, 1997).
Xu, L. et al. Immunization for Ebola virus infection. Nature Med. 4, 37–42 (1998).
Shope, R.E. & Test, R.B. The ecology of rhabdoviruses that infect vertebrates. In The rhabdoviruses (ed. Wagner, R.R.) 509–534 (Plenum Press, New York, 1987).
Feldmann, H. & Klenk, H-D. In Marburg and Ebola Viruses. (Academic Press, Inc., San Diego, 1996).
Volchkov, V.E., Blinov, V.M. & Netesov, S.V. The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses. FEBS Lett. 305, 181–184 (1992).
Iwasaki, A., Torres, C.A.T., Ohashi, P.S., Robinson, H.L. & Barber, B.H. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159, 11–14 (1997).
Lupton, H.W., Lambert, R.D., Bumgardner, D.L., Moe, J.B. & Eddy, G.A. Inactivated vaccine for Ebola virus efficacious in guinea pig model. Lancet. 1294–1295 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Folks, T. Ebola takes a punch. Nat Med 4, 16–17 (1998). https://doi.org/10.1038/nm0198-016
Issue Date:
DOI: https://doi.org/10.1038/nm0198-016